Hakan Bozcuk

Summary

Affiliation: Akdeniz University
Country: Turkey

Publications

  1. ncbi Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: a meta-analytical approach with meta-regression analysis
    H Bozcuk
    Akdeniz University Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    J BUON 15:43-50. 2010
  2. ncbi Does awareness of diagnosis make any difference to quality of life? Determinants of emotional functioning in a group of cancer patients in Turkey
    H Bozcuk
    Akdeniz University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    Support Care Cancer 10:51-7. 2002
  3. ncbi Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma
    Ahter D Sanlioglu
    The Human Gene Therapy Unit, Faculty of Medicine, Akdeniz University Campus, B Block, 1st Floor, Antalya 07070, Turkey
    Lung Cancer 44:199-211. 2004
  4. ncbi Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study
    Mustafa Yildiz
    Pamukkale University Medical Faculty, Department of Medical Oncology, Denizli, Turkey
    Cell Biol Int 30:278-82. 2006
  5. ncbi Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre
    H Bozcuk
    Oncology Division, Department of Internal Medicine, Akdeniz University Medical Faculty, Antalya 07070, Turkey
    Lung Cancer 34:243-52. 2001
  6. ncbi A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients
    H Bozcuk
    Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey
    Int J Clin Pract 58:1014-9. 2004
  7. ncbi Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy
    Hakan Bozcuk
    Akdeniz University Medical Faculty, Department of Medical Oncology, Dumlupinar Bulvari, 07070 Antalya, Turkey
    Cytokine 27:58-65. 2004
  8. ncbi Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer
    Hakan Bozcuk
    Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
    Med Sci Monit 11:HY11-20. 2005
  9. ncbi Does music exposure during chemotherapy improve quality of life in early breast cancer patients? A pilot study
    Hakan Bozcuk
    Akdeniz University Medical Faculty, Dept of Medical Oncology, Antalya, Turkey
    Med Sci Monit 12:CR200-5. 2006
  10. ncbi Quality of life in patients with advanced non-small cell lung cancer
    Hakan Bozcuk
    Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
    Cancer Nurs 29:104-10. 2006

Collaborators

Detail Information

Publications22

  1. ncbi Correlates of benefit from neoadjuvant chemotherapy before radiotherapy in non-small cell lung cancer: a meta-analytical approach with meta-regression analysis
    H Bozcuk
    Akdeniz University Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    J BUON 15:43-50. 2010
    ..In this setting, we assessed the predictors of benefit from neoadjuvant chemotherapy before radiotherapy...
  2. ncbi Does awareness of diagnosis make any difference to quality of life? Determinants of emotional functioning in a group of cancer patients in Turkey
    H Bozcuk
    Akdeniz University School of Medicine, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    Support Care Cancer 10:51-7. 2002
    ..On the contrary, those with hepatic dysfunction, female gender, poor social functioning and constipation are the ones at increased risk of poor emotional functioning, and these patients may benefit from psychological screening...
  3. ncbi Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma
    Ahter D Sanlioglu
    The Human Gene Therapy Unit, Faculty of Medicine, Akdeniz University Campus, B Block, 1st Floor, Antalya 07070, Turkey
    Lung Cancer 44:199-211. 2004
    ..Current progress in clinical trials using adenovirus-mediated delivery of TNF-alpha is also discussed...
  4. ncbi Zoledronic acid is synergic with vinblastine to induce apoptosis in a multidrug resistance protein-1 dependent way: an in vitro study
    Mustafa Yildiz
    Pamukkale University Medical Faculty, Department of Medical Oncology, Denizli, Turkey
    Cell Biol Int 30:278-82. 2006
    ..3%, P < 0.001). This preliminary work shows that zoledronic acid acts synergistically with vinblastine to induce apoptosis in an MRP-1 dependent way...
  5. ncbi Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre
    H Bozcuk
    Oncology Division, Department of Internal Medicine, Akdeniz University Medical Faculty, Antalya 07070, Turkey
    Lung Cancer 34:243-52. 2001
    ....
  6. ncbi A simple and accurate prediction model to estimate the intrahospital mortality risk of hospitalised cancer patients
    H Bozcuk
    Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya, Turkey
    Int J Clin Pract 58:1014-9. 2004
    ..88 in the derivation cohort and 0.82 in the validation cohort. Using readily available clinical parameters, it is possible to devise an accurate and applicable risk prediction model for the hospitalised cancer patients...
  7. ncbi Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy
    Hakan Bozcuk
    Akdeniz University Medical Faculty, Department of Medical Oncology, Dumlupinar Bulvari, 07070 Antalya, Turkey
    Cytokine 27:58-65. 2004
    ..To assess the relationship of various growth factors and cytokines with the clinical outcome in metastatic breast cancer patients receiving chemotherapy...
  8. ncbi Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer
    Hakan Bozcuk
    Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
    Med Sci Monit 11:HY11-20. 2005
    ..We aimed to identify the roles of P53, c-erb- B2 and p-glycoprotein (pgp) as prognostic factors, independently or in conjunction with each other, in operable NSCLC...
  9. ncbi Does music exposure during chemotherapy improve quality of life in early breast cancer patients? A pilot study
    Hakan Bozcuk
    Akdeniz University Medical Faculty, Dept of Medical Oncology, Antalya, Turkey
    Med Sci Monit 12:CR200-5. 2006
    ..Adjuvant chemotherapy is associated with poor quality of life (qol) in breast cancer patients. We tested the effect of listening to music during chemotherapy on quality of life in these patients...
  10. ncbi Quality of life in patients with advanced non-small cell lung cancer
    Hakan Bozcuk
    Department of Medical Oncology, Faculty of Medicine, Akdeniz University, Antalya, Turkey
    Cancer Nurs 29:104-10. 2006
    ..Conversely, in this cohort, patients who are likely to have deteriorating QOL on chemotherapy may benefit from closer follow-up and nursing care to optimize supportive measures...
  11. ncbi The impact of waist-to-hip ratio on clinical outcomes in metastatic breast cancer patients treated with aromatase inhibitors
    Mehmet Artac
    Division of Medical Oncology, Meram Medical Faculty, Selcuk University, Konya, Turkey
    Breast 17:418-22. 2008
    ..92 and >or=0.92 were 423 versus 1004 days (Log rank statistic=6.37, P=0.012). This study suggests that WHR may serve as a potential predictive marker in MBC patients treated with AIs...
  12. ncbi Does maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials
    Hakan Bozcuk
    Akdeniz University Medical Faculty, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    Cancer 104:2650-7. 2005
    ..The role of maintenance/consolidation chemotherapy was assessed in the management of small cell lung cancer (SCLC) via a metaanalytic approach...
  13. ncbi The value of XPD and XRCC1 genotype polymorphisms to predict clinical outcome in metastatic colorectal carcinoma patients with irinotecan-based regimens
    Mehmet Artac
    Department of Medical Oncology, Meram Medical Faculty, Selcuk University, Meram, 42080 Konya, Turkey
    J Cancer Res Clin Oncol 136:803-9. 2010
    ..Previous studies have suggested that DNA repair enzyme polymorphisms may bear prognostic value in metastatic colorectal carcinoma (MCRC)...
  14. ncbi Different clinical features of primary and secondary tumors in patients with multiple malignancies
    Mehmet Artac
    Akdeniz University Medical School, Department of Internal Medicine, Division of Medical Oncology, Antalya, Turkey
    Tumori 91:317-20. 2005
    ..Thus, we recommend a long screening time for secondary tumors after a curative treatment in patients with common cancers, taking into account the different occurrence patterns of second primaries with respect to first primaries...
  15. ncbi An application of a genetic algorithm in conjunction with other data mining methods for estimating outcome after hospitalization in cancer patients
    Hakan Bozcuk
    Department of Medical Oncology, Akdeniz University Medical Faculty, Antalya 07070, Turkey
    Med Sci Monit 10:CR246-51. 2004
    ..We investigated which factors predicted the risk of in-hospital mortality in a general population of cancer patients with non-terminal disease and whether employing the genetic algorithm technique would be useful in this regard...
  16. ncbi Low-grade inflammation in white-coat hypertension
    Mustafa Ozdogan
    Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
    Med Sci Monit 13:CR570-3. 2007
    ..The risk profile of white-coat hypertension is not yet completely clear. The aim of this study was to determine the levels of high-sensitivity CRP (hs-CRP) in white-coat hypertensive subjects...
  17. ncbi Small cell carcinoma of the cervix: a case report
    Aylin Fidan Korcum
    Department of Radiation Oncology, Akdeniz University, School of Medicine, 07070, Antalya, Turkey
    Arch Gynecol Obstet 277:367-70. 2008
    ..Subsequently, they were treated with pelvic external radiotherapy and high-dose-rate intracavitary brachytherapy with concurrent cisplatin based chemotherapy. They were alive with no evidence of disease at 91 and 65 months, respectively...
  18. ncbi The value of CEA and CA 19-9 in detecting cancer in a group of high-risk subjects with gastrointestinal symptoms
    E Coban
    Department of Internal Medicine, Akdeniz University Faculty of Medicine, Antalya, Turkey
    Int J Biol Markers 18:177-81. 2003
    ..In conclusion, in patients presenting with gastrointestinal complaints, the finding of elevated CEA levels may help in the diagnosis of cancer by prompting a more extensive search for intraabdominal cancer...
  19. ncbi The value of low-dose intraperitoneal immunoglobulin administration in the treatment of peritoneal dialysis-related peritonitis
    Erkan Coban
    Department of Internal Medicine, Faculty of Medicine, Akdeniz University, Antalya, Turkey
    J Nephrol 17:427-30. 2004
    ..In this study, the effect of intraperitoneal (IP) immunoglobulin (Ig) usage, as an approach for strengthening opsonization, was evaluated in CAPD peritonitis...
  20. ncbi Predictors of distant metastasis at presentation in breast cancer: a study also evaluating associations among common biological indicators
    H Bozcuk
    Department of Internal Medicine, Akdeniz University Medical Faculty, Antalya, Turkey
    Breast Cancer Res Treat 68:239-48. 2001
    ..To investigate the correlation among some of the commonly used clinical, pathological factors and newer biological indicators, and to identify the independent predictors of distant metastasis at presentation in patients with breast cancer...
  21. ncbi Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study
    O H Ozturk
    Akdeniz University, Department of Biochemistry, Antalya, Turkey
    Cell Biol Int 31:1069-71. 2007
    ..Thus, we show for the first time in a lung cancer cell line that zoledronic acid bears cytotoxic potential on its own and in conjunction with cisplatin. The clinical potential of this finding should be further studied...
  22. ncbi The debate about maintenance is not over in small-cell lung cancer
    Mehmet Artac
    J Clin Oncol 25:5840; author reply 5840-1. 2007